deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT03785340

Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)

A Phase 3 Randomized, Placebo-Controlled, Double-Masked, Multicenter, Safety and Efficacy Study of Brimonidine Tartrate 0.2% Nanoemulsion Eye Drops in Patients With Dry Eye Disease (DED)

Sponsor: Ocugen

Conditions Dry Eye
Updated 9 times since 2019 Last updated: Jun 29, 2022 Started: Dec 3, 2018 Primary completion: Feb 25, 2019 Completion: Feb 25, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Dry Eye and is currently completed. Ocugen leads this study, which shows 9 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshotRecruiting~Feb 2019 – ~Aug 2020 · 18 months · monthly snapshotRecruiting~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2022 · 18 months · monthly snapshotCompleted~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshotCompleted~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Sep 2022 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jul 2022 — Sep 2022 [monthly]

    Completed PHASE3

Show 4 earlier versions
  1. Jan 2021 — Jul 2022 [monthly]

    Completed PHASE3

  2. Aug 2020 — Jan 2021 [monthly]

    Completed PHASE3

    Status: RecruitingCompleted

  3. Feb 2019 — Aug 2020 [monthly]

    Recruiting PHASE3

  4. Jan 2019 — Feb 2019 [monthly]

    Recruiting PHASE3

    First recorded

Dec 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ocugen
Data source: Ocugen

For direct contact, visit the study record on ClinicalTrials.gov .